交易 Denali Therapeutics - DNLI CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.13 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Denali Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“B”分數表示相對 ESG 表現良好,公開報告重要 ESG 數據的透明度高於平均水平。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 16.53 | -0.12 | -0.72% | 16.65 | 16.88 | 16.46 |
Apr 17, 2024 | 16.76 | -0.53 | -3.07% | 17.29 | 17.45 | 16.73 |
Apr 16, 2024 | 17.28 | -0.22 | -1.26% | 17.50 | 17.52 | 17.05 |
Apr 15, 2024 | 17.78 | -0.36 | -1.98% | 18.14 | 18.14 | 17.64 |
Apr 12, 2024 | 18.17 | -0.33 | -1.78% | 18.50 | 18.86 | 17.79 |
Apr 11, 2024 | 19.11 | 0.66 | 3.58% | 18.45 | 19.14 | 18.42 |
Apr 10, 2024 | 18.33 | -0.08 | -0.43% | 18.41 | 18.47 | 17.96 |
Apr 9, 2024 | 19.39 | 0.54 | 2.86% | 18.85 | 19.66 | 18.85 |
Apr 8, 2024 | 18.99 | -0.37 | -1.91% | 19.36 | 19.51 | 18.82 |
Apr 5, 2024 | 19.33 | 0.62 | 3.31% | 18.71 | 19.35 | 18.20 |
Apr 4, 2024 | 18.90 | -0.57 | -2.93% | 19.47 | 19.55 | 18.89 |
Apr 3, 2024 | 19.31 | 0.36 | 1.90% | 18.95 | 19.35 | 18.90 |
Apr 2, 2024 | 19.30 | -0.65 | -3.26% | 19.95 | 19.95 | 18.95 |
Apr 1, 2024 | 20.51 | 0.08 | 0.39% | 20.43 | 20.67 | 19.96 |
Mar 28, 2024 | 20.43 | -0.29 | -1.40% | 20.72 | 20.98 | 20.06 |
Mar 27, 2024 | 20.72 | 0.89 | 4.49% | 19.83 | 20.86 | 19.75 |
Mar 26, 2024 | 19.81 | -0.17 | -0.85% | 19.98 | 20.11 | 19.40 |
Mar 25, 2024 | 19.80 | 0.53 | 2.75% | 19.27 | 19.88 | 19.27 |
Mar 22, 2024 | 19.55 | -1.28 | -6.14% | 20.83 | 20.93 | 19.51 |
Mar 21, 2024 | 20.92 | -0.33 | -1.55% | 21.25 | 21.36 | 20.87 |
Denali Therapeutics Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 6, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 Denali Therapeutics Inc Earnings Release Q1 2024 Denali Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, May 31, 2024 | ||
時間 (UTC) 17:00 | 國家 US
| 事件 Denali Therapeutics Inc Annual Shareholders Meeting Denali Therapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Tuesday, August 6, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q2 2024 Denali Therapeutics Inc Earnings Release Q2 2024 Denali Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 108.463 | 48.661 | 335.659 | 26.678 | 129.16 |
總營業費用 | 449.207 | 344.412 | 272.941 | 239.862 | 175.532 |
銷售/一般/行政費用,總計 | 90.475 | 79.059 | 60.326 | 46.48 | 32.349 |
研究與開發 | 358.732 | 265.353 | 212.615 | 193.382 | 143.183 |
營業收入 | -340.744 | -295.751 | 62.718 | -213.184 | -46.372 |
利息收入(費用),非經營淨值 | 14.774 | 4.595 | 9.241 | 15.219 | 10.132 |
稅前淨收入 | -325.97 | -291.156 | 71.959 | -197.965 | -36.24 |
稅後淨收入 | -325.991 | -290.581 | 71.136 | -197.614 | -36.24 |
未計算非常項目前的淨收益 | -325.991 | -290.581 | 71.136 | -197.614 | -36.24 |
淨收入 | -325.991 | -290.581 | 71.136 | -197.614 | -36.24 |
普通股股東可獲收益 (不含非經常性項目) | -325.991 | -290.581 | 71.136 | -197.614 | -36.24 |
普通股股東可獲收益 (含非經常性項目) | -325.991 | -290.581 | 71.136 | -197.614 | -36.24 |
攤薄調整 | |||||
攤薄淨收入 | -325.991 | -290.581 | 71.136 | -197.614 | -36.24 |
攤薄後加權平均股 | 125.531 | 121.525 | 112.703 | 95.6082 | 92.622 |
扣除特別項目的每股攤薄盈利 | -2.5969 | -2.39113 | 0.63118 | -2.06691 | -0.39127 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -2.5969 | -2.39113 | 0.63118 | -2.06691 | -0.39127 |
收入 | 108.463 | 48.661 | 335.659 | 26.678 | 129.16 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 294.123 | 35.141 | 10.283 | 3.559 | 52.48 |
收入 | 294.123 | 35.141 | 10.283 | 3.559 | 52.48 |
總營業費用 | 123.64 | 155.956 | 115.627 | 111.045 | 113.896 |
銷售/一般/行政費用,總計 | 26.12 | 27.14 | 23.516 | 23.259 | 21.159 |
研究與開發 | 97.52 | 128.816 | 92.111 | 87.786 | 92.737 |
營業收入 | 170.483 | -120.815 | -105.344 | -107.486 | -61.416 |
利息收入(費用),非經營淨值 | 12.9 | 11.034 | 6.66 | 4.187 | 2.649 |
稅前淨收入 | 183.383 | -109.781 | -98.684 | -103.299 | -58.767 |
稅後淨收入 | 183.383 | -109.781 | -98.678 | -103.299 | -58.794 |
未計算非常項目前的淨收益 | 183.383 | -109.781 | -98.678 | -103.299 | -58.794 |
淨收入 | 183.383 | -109.781 | -98.678 | -103.299 | -58.794 |
普通股股東可獲收益 (不含非經常性項目) | 183.383 | -109.781 | -98.678 | -103.299 | -58.794 |
普通股股東可獲收益 (含非經常性項目) | 183.383 | -109.781 | -98.678 | -103.299 | -58.794 |
攤薄淨收入 | 183.383 | -109.781 | -98.678 | -103.299 | -58.794 |
攤薄後加權平均股 | 140.931 | 136.525 | 132.958 | 123.473 | 123.009 |
扣除特別項目的每股攤薄盈利 | 1.30123 | -0.80411 | -0.74217 | -0.83661 | -0.47797 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | 1.30123 | -0.80411 | -0.74217 | -0.83661 | -0.47797 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 1372.32 | 897.234 | 1495.66 | 430.031 | 480.836 |
現金和短期投資 | 1336.21 | 865.407 | 1469.7 | 415.356 | 464.297 |
現金等價物 | 218.044 | 293.477 | 507.144 | 79.449 | 77.123 |
短期投資 | 1118.17 | 571.93 | 962.553 | 335.907 | 387.174 |
應收賬款總額,淨額 | 0 | 1.226 | 5.674 | 1.182 | |
應收賬款 - 貿易,淨額 | 1.182 | ||||
預付的費用 | 36.104 | 30.601 | 20.284 | 14.675 | 15.357 |
總資産 | 1460.24 | 1404.16 | 1604.28 | 553.231 | 661.984 |
物業/廠房/設備,總計 - 淨額 | 74.524 | 69.608 | 73.464 | 80.655 | 25.162 |
物業/廠房/設備,總計 - 總額 | 111.739 | 98.952 | 94.266 | 92.928 | 37.172 |
累計折舊,總計 | -37.215 | -29.344 | -20.802 | -12.273 | -12.01 |
長期投資 | 0 | 425.449 | 32.699 | 39.886 | 147.881 |
其他長期資産,總計 | 13.399 | 11.871 | 2.462 | 2.659 | 8.105 |
流動負債總額 | 363.922 | 378.245 | 71.699 | 45.344 | 32.786 |
應付賬款 | 2.79 | 4.779 | 1.071 | 2.59 | 1.891 |
預提費用 | 66.691 | 53.165 | 47.145 | 24.007 | 18.472 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 294.441 | 320.301 | 23.483 | 18.747 | 12.423 |
負債總額 | 417.812 | 441.871 | 453.749 | 158.341 | 115.139 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 53.89 | 63.626 | 382.05 | 112.997 | 82.353 |
股權 | 1042.43 | 962.291 | 1150.53 | 394.89 | 546.845 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
普通股 | 1.686 | 1.548 | 1.531 | 1.288 | 1.273 |
額外實收資本 | 2018.62 | 1608.24 | 1503.66 | 818.803 | 774.158 |
留存收益(累計赤字) | -970.987 | -644.996 | -354.415 | -425.551 | -227.937 |
其他權益,總計 | -6.886 | -2.499 | -0.245 | 0.35 | -0.649 |
總負債和股東權益 | 1460.24 | 1404.16 | 1604.28 | 553.231 | 661.984 |
已發行普通股總數 | 135.966 | 122.283 | 120.531 | 96.1899 | 94.6624 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 1142.88 | 1224.06 | 1325.16 | 1372.32 | 1138.53 |
現金和短期投資 | 1107.66 | 1190.99 | 1288.45 | 1336.21 | 1106.06 |
現金等價物 | 146.411 | 131.973 | 68.131 | 218.044 | 118.615 |
短期投資 | 961.245 | 1059.01 | 1220.32 | 1118.17 | 987.44 |
應收賬款總額,淨額 | 0 | 0 | |||
預付的費用 | 33.628 | 33.075 | 36.709 | 36.104 | 32.471 |
總資産 | 1236.78 | 1305.73 | 1409.34 | 1460.24 | 1227.61 |
物業/廠房/設備,總計 - 淨額 | 74.851 | 67.238 | 70.166 | 74.524 | 72.963 |
長期投資 | 7.905 | 0 | 0 | ||
其他長期資産,總計 | 11.137 | 14.434 | 14.016 | 13.399 | 16.117 |
流動負債總額 | 71.18 | 69.357 | 391.08 | 363.922 | 360.67 |
應付賬款 | 1.182 | 8.52 | 2.215 | 2.79 | 7.539 |
預提費用 | 59.644 | 53.016 | 90.57 | 66.691 | 61.149 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 10.354 | 7.821 | 298.295 | 294.441 | 291.982 |
負債總額 | 118.446 | 118.909 | 442.638 | 417.812 | 416.303 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 47.266 | 49.552 | 51.558 | 53.89 | 55.633 |
股權 | 1118.33 | 1186.82 | 966.706 | 1042.43 | 811.303 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
普通股 | 1.707 | 1.7 | 1.694 | 1.686 | 1.564 |
額外實收資本 | 2114.01 | 2083.95 | 2048.3 | 2018.62 | 1693.9 |
留存收益(累計赤字) | -996.738 | -897.385 | -1080.77 | -970.987 | -872.309 |
其他權益,總計 | -0.651 | -1.441 | -2.517 | -6.886 | -11.853 |
總負債和股東權益 | 1236.78 | 1305.73 | 1409.34 | 1460.24 | 1227.61 |
已發行普通股總數 | 138.052 | 137.363 | 136.742 | 135.966 | 123.796 |
其他流動資産,總計 | 1.6 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -325.991 | -290.581 | 71.136 | -197.614 | -36.24 |
經營活動産生的現金 | -244.716 | -211.389 | 416.152 | -151.576 | 50.116 |
經營活動産生的現金 | 10.383 | 8.593 | 8.531 | 7.991 | 7.415 |
非現金物品 | 94.922 | 93.995 | 50.444 | 33.872 | 16.05 |
營運資金的變化 | -24.03 | -23.396 | 286.041 | 4.175 | 62.891 |
投資活動産生的現金 | -141.387 | -21.626 | -623.206 | 147.712 | -287.422 |
資本支出 | -17.833 | -8.5 | -3.095 | -17.919 | -3.393 |
其他投資現金流量項目,總計 | -123.554 | -13.126 | -620.111 | 165.631 | -284.029 |
融資活動産生的現金 | 310.67 | 19.348 | 634.749 | 6.19 | 97.019 |
融資現金流項目 | 0 | -1.386 | |||
股票的發行(報廢),淨額 | 310.67 | 19.348 | 634.749 | 6.19 | 98.405 |
現金淨變化 | -75.433 | -213.667 | 427.695 | 2.326 | -140.287 |
債務的發行(退還),淨額 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -109.781 | -325.991 | -227.313 | -124.014 | -65.22 |
Cash From Operating Activities | -58.802 | -244.716 | -172.053 | -115.007 | -72.109 |
Cash From Operating Activities | 10.047 | 10.383 | 6.292 | 4.151 | 2.079 |
Non-Cash Items | 19.354 | 94.922 | 73.653 | 50.581 | 26.989 |
Changes in Working Capital | 21.578 | -24.03 | -24.685 | -45.725 | -35.957 |
Cash From Investing Activities | -92.715 | -141.387 | -13.828 | -29.247 | -117.878 |
Capital Expenditures | -2.786 | -17.833 | -12.984 | -6.934 | -4.041 |
Other Investing Cash Flow Items, Total | -89.929 | -123.554 | -0.844 | -22.313 | -113.837 |
Cash From Financing Activities | 1.604 | 310.67 | 11.019 | 5.865 | 1.463 |
Issuance (Retirement) of Stock, Net | 1.604 | 310.67 | 11.019 | 5.865 | 1.463 |
Net Change in Cash | -149.913 | -75.433 | -174.862 | -138.389 | -188.524 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
161 Oyster Point Blvd
SOUTH SAN FRANCISCO
CALIFORNIA 94080-1910
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易